the study about the effectiveness of the amniocentesis for the threatened premature delivery

the study about the effectiveness of the amniocentesis for the threatened premature delivery - the study about the effectiveness of the amniocentesis for the threatened premature delivery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027396

Enrollment

100

Registered

2017-05-18

Start date

2017-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

threatened premature delivery

Interventions

When we recognize the high levels of the inflammations related substances in the amniotic fluid, we may use the antibiotic medicine for more long term than usually.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The pregnant women who diagnosed threatened premature delivery (more than 22 weeks of gestation, less than 36 weeks of gestation)

Exclusion criteria

Exclusion criteria: The case of the clinical chorioamnionitis, malformation of the fetus, multiple pregnancy, placenta previa, low set of placenta, the cases who are difficult to amniocentesis

Design outcomes

Primary

Measure	Time frame
The relationship between the inflammation related substances and the therapeutic effect of the threatened premature delivery.	—

Countries

Japan

Contacts

Public ContactYukiko Mikami

Saitama Medical Center, Saitama Medical University Department of Obstetrics and Gynecology

ymikami@saitama-med.ac.jp049-228-3681

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026